Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ADBE
2. RH
3. NVDA
4. USO
5. SPCX
6. NDAQ
7. MH
8. TFPM
9. BBW
10. RKLB

Go back to Elutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA Clearance

Elutia Inc. (ELUT) Misses Q1 EPS by 43c

May 9, 2024 4:22 PM EDT

Elutia Inc. (NASDAQ: ELUT) reported Q1 EPS of ($0.75), $0.43 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $6.7 million versus the consensus estimate of $6.3 million.

For earnings history and earnings-related data on Elutia Inc. (ELUT) click here.

... More